1276 related articles for article (PubMed ID: 19759492)
1. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
[TBL] [Abstract][Full Text] [Related]
2. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
[TBL] [Abstract][Full Text] [Related]
3. A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates.
Tsakris A; Poulou A; Pournaras S; Voulgari E; Vrioni G; Themeli-Digalaki K; Petropoulou D; Sofianou D
J Antimicrob Chemother; 2010 Aug; 65(8):1664-71. PubMed ID: 20542902
[TBL] [Abstract][Full Text] [Related]
4. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
5. Use of several inducer and substrate antibiotic combinations in a disk approximation assay format to screen for AmpC induction in patient isolates of Pseudomonas aeruginosa, Enterobacter spp., Citrobacter spp., and Serratia spp.
Dunne WM; Hardin DJ
J Clin Microbiol; 2005 Dec; 43(12):5945-9. PubMed ID: 16333080
[TBL] [Abstract][Full Text] [Related]
6. Extended double disc synergy testing reveals a low prevalence of extended-spectrum beta-lactamases in Enterobacter spp. in Vienna, Austria.
Apfalter P; Assadian O; Daxböck F; Hirschl AM; Rotter ML; Makristathis A
J Antimicrob Chemother; 2007 May; 59(5):854-9. PubMed ID: 17347178
[TBL] [Abstract][Full Text] [Related]
7. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of extended-spectrum β-lactamases and qnr determinants in Citrobacter species from Japan: dissemination of CTX-M-2.
Kanamori H; Yano H; Hirakata Y; Endo S; Arai K; Ogawa M; Shimojima M; Aoyagi T; Hatta M; Yamada M; Nishimaki K; Kitagawa M; Kunishima H; Kaku M
J Antimicrob Chemother; 2011 Oct; 66(10):2255-62. PubMed ID: 21733965
[TBL] [Abstract][Full Text] [Related]
9. Activity of faropenem against cephalosporin-resistant Enterobacteriaceae.
Mushtaq S; Hope R; Warner M; Livermore DM
J Antimicrob Chemother; 2007 May; 59(5):1025-30. PubMed ID: 17353220
[TBL] [Abstract][Full Text] [Related]
10. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates.
Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M
J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269
[TBL] [Abstract][Full Text] [Related]
11. Convenient test using a combination of chelating agents for detection of metallo-beta-lactamases in the clinical laboratory.
Kim SY; Hong SG; Moland ES; Thomson KS
J Clin Microbiol; 2007 Sep; 45(9):2798-801. PubMed ID: 17596358
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
Taneja N; Rao P; Arora J; Dogra A
Indian J Med Res; 2008 Jan; 127(1):85-8. PubMed ID: 18316858
[TBL] [Abstract][Full Text] [Related]
13. Towards a phenotypic screening strategy for emerging β-lactamases in Gram-negative bacilli.
Willems E; Verhaegen J; Magerman K; Nys S; Cartuyvels R
Int J Antimicrob Agents; 2013 Feb; 41(2):99-109. PubMed ID: 23280443
[TBL] [Abstract][Full Text] [Related]
14. A simple disc diffusion method for detecting AmpC and extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae.
Derbyshire H; Kay G; Evans K; Vaughan C; Kavuri U; Winstanley T
J Antimicrob Chemother; 2009 Mar; 63(3):497-501. PubMed ID: 19155228
[TBL] [Abstract][Full Text] [Related]
15. Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup.
Capoor MR; Nair D; Srivastava L; Gupta B; Aggarwal P
J Commun Dis; 2005 Jun; 37(2):99-107. PubMed ID: 16749272
[TBL] [Abstract][Full Text] [Related]
16. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures.
Wiegand I; Geiss HK; Mack D; Stürenburg E; Seifert H
J Clin Microbiol; 2007 Apr; 45(4):1167-74. PubMed ID: 17287329
[TBL] [Abstract][Full Text] [Related]
17. [The expression of AmpC and extended-spectrum beta-lactamases among clinical isolates of enterobacter cloacae and its impact on antibiotics susceptibility].
She D; Liu Y
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1355-8. PubMed ID: 12509943
[TBL] [Abstract][Full Text] [Related]
18. Boronic acid disk tests for identification of extended-spectrum beta-lactamase production in clinical isolates of Enterobacteriaceae producing chromosomal AmpC beta-lactamases.
Jeong SH; Song W; Park MJ; Kim JS; Kim HS; Bae IK; Lee KM
Int J Antimicrob Agents; 2008 May; 31(5):467-71. PubMed ID: 18337065
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria.
Park YJ; Park SY; Oh EJ; Park JJ; Lee KY; Woo GJ; Lee K
Diagn Microbiol Infect Dis; 2005 Apr; 51(4):265-9. PubMed ID: 15808318
[TBL] [Abstract][Full Text] [Related]
20. [Clinical isolates of Pseudomonas aeruginosa producers of extended spectrum beta-lactamases at a private institution in Cordoba].
Piersigilli AL; Enrico MC; Bongiovanni ME; Bilbao LE; Martínez G; Ledesma EM
Rev Chilena Infectol; 2009 Aug; 26(4):331-5. PubMed ID: 19802399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
